Latest Market Expectations News

Capral Limited reported half-year earnings in line with expectations despite a 7% decline in volume, buoyed by higher aluminium prices and disciplined cost management. The company anticipates a residential market rebound in the second half of 2025 amid ongoing industrial softness.

Andromeda Metals has addressed recent share price gains and trading volume spikes, attributing the activity to ongoing funding efforts and strategic project studies rather than undisclosed information.

SEEK Limited has released its FY2025 full year results presentation, offering insights into its financial and operational performance amid evolving market dynamics.

Deterra Royalties delivered a robust FY25 with a 10% revenue increase and a strategic acquisition that diversifies its commodity exposure. The company’s flagship iron ore royalty remains a strong cash generator as the Thacker Pass lithium project moves into construction.

Macmahon Holdings has posted record FY25 results, buoyed by Decmil integration and strong mining contract wins, while raising its FY26 revenue and earnings guidance.

Citigroup Global Markets Australia has declared a partially franked dividend of AUD 0.31 for QBE CitiFirst Self-Funding Instalment MINI warrants, set to reduce outstanding loan amounts and begin trading ex-dividend on 19 August 2025.

Contact Energy's July 2025 report reveals stable electricity sales with improved netback prices and significantly reduced generation costs, alongside ongoing investments in renewable projects.

Audalia Resources has reported significant assay results from its recent infill drilling at the Medcalf vanadium-titanium-iron project in Western Australia, confirming consistent mineralisation and progressing towards an updated resource estimate.

Abacus Storage King has reported a robust FY25 with a $289 million net profit and steady distribution guidance, while advancing its growth and sustainability agenda amid ongoing takeover discussions.

ASX Limited has announced a fully franked ordinary dividend of AUD 1.121 per share for the half-year ending June 2025, alongside a dividend reinvestment plan offering shareholders flexible currency choices.

Amotiv Limited has announced a fully franked ordinary dividend of AUD 0.22 per share for the financial year ending June 2025, payable in September. The dividend reflects the company’s steady financial position and commitment to shareholder returns.

Tryptamine Therapeutics has locked in $2.6 million in non-dilutive funding to fast-track clinical trials of its lead psilocin-based therapy, TRP-8803, targeting binge eating disorder and other conditions.